M
Mohamed A. Bedaiwy
Researcher at University of British Columbia
Publications - 280
Citations - 8593
Mohamed A. Bedaiwy is an academic researcher from University of British Columbia. The author has contributed to research in topics: Endometriosis & Pregnancy. The author has an hindex of 43, co-authored 253 publications receiving 7364 citations. Previous affiliations of Mohamed A. Bedaiwy include University of Toronto & University Hospitals of Cleveland.
Papers
More filters
Journal ArticleDOI
Role of reactive oxygen species in the pathophysiology of human reproduction
TL;DR: High levels of ROS are detrimental to the fertility potential both in natural and assisted conception states.
Journal ArticleDOI
Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial
Mohamed A. Bedaiwy,Tommaso Falcone,Rakesh Sharma,J.M. Goldberg,Marjan Attaran,David R. Nelson,Ashok Agarwal +6 more
TL;DR: By measuring serum IL-6 and PF TNF-alpha, it was possible to discriminate between patients with endometriosis and those without, and before these markers can be used as a non-surgical diagnostic tool, these data should be verified in a larger study.
Journal ArticleDOI
Oxidative stress in an assisted reproductive techniques setting.
TL;DR: Many modifiable conditions exist in an ART setting that may aid in reducing the toxic effects of ROS, and the main objective of this review is to provide ART personnel with all the necessary information regarding the development of oxidative stress in anART setting.
Journal ArticleDOI
Role of nuclear progesterone receptor isoforms in uterine pathophysiology
TL;DR: PRs are key mediators of progesterone action in uterine tissues and are essential for normal uterine function, and may regulate key immunogenic factors involved in RPL.
Journal ArticleDOI
Differential growth of human embryos in vitro: Role of reactive oxygen species
Mohamed A. Bedaiwy,Tommaso Falcone,Maher S. Mohamed,Abdel A.N. Aleem,Rakesh Sharma,Sarah Worley,Julie Thornton,Ashok Agarwal +7 more
TL;DR: High day 1 ROS levels in culture media were associated with lower pregnancy rates in both IVF and ICSI cycles and may be an important biochemical marker for early embryonic growth.